• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新兴 SARS-CoV-2 变体 B.1.1.529 的刺突糖蛋白的功能特性。

Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529.

机构信息

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Department of Microbiology, Harvard Medical School, Boston, MA 02215, USA.

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Department of Microbiology, Harvard Medical School, Boston, MA 02215, USA.

出版信息

Cell Rep. 2022 Jun 14;39(11):110924. doi: 10.1016/j.celrep.2022.110924. Epub 2022 May 20.

DOI:10.1016/j.celrep.2022.110924
PMID:35658975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9119962/
Abstract

The recently emerged B.1.1.529 (Omicron) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant has a highly divergent spike (S) glycoprotein. We compared the functional properties of B.1.1.529 BA.1 S with those of previous globally prevalent SARS-CoV-2 variants, D614G and B.1.617.2. Relative to these variants, B.1.1.529 S exhibits decreases in processing, syncytium formation, virion incorporation, and ability to mediate infection of cells with high TMPRSS2 expression. B.1.1.529 and B.1.617.2 S glycoproteins bind ACE2 with higher affinity than D614G S. The unliganded B.1.1.529 S trimer is less stable at low temperatures than the other SARS-CoV-2 Ss, a property related to its more "open" S conformation. Upon ACE2 binding, the B.1.1.529 S trimer sheds S1 at 37°C, but not at 0°C. B.1.1.529 pseudoviruses are relatively resistant to neutralization by sera from patients with coronavirus disease 2019 (COVID-19) and vaccinees. These properties of the B.1.1.529 S glycoprotein likely influence the transmission, cytopathic effects, and immune evasion of this emerging variant.

摘要

最近出现的 B.1.1.529(奥密克戎)严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)变体具有高度分化的刺突(S)糖蛋白。我们比较了 B.1.1.529 BA.1 S 与之前全球流行的 SARS-CoV-2 变体 D614G 和 B.1.617.2 的功能特性。与这些变体相比,B.1.1.529 S 的加工、合胞体形成、病毒粒子掺入以及介导高 TMPRSS2 表达细胞感染的能力降低。B.1.1.529 和 B.1.617.2 S 糖蛋白与 ACE2 的结合亲和力高于 D614G S。未结合的 B.1.1.529 S 三聚体在低温下比其他 SARS-CoV-2 S 更不稳定,这种特性与其更“开放”的 S 构象有关。在 ACE2 结合后,B.1.1.529 S 三聚体在 37°C 下但不在 0°C 下脱落 S1。B.1.1.529 假病毒对来自 2019 年冠状病毒病(COVID-19)患者和疫苗接种者的血清的中和作用具有相对抗性。B.1.1.529 S 糖蛋白的这些特性可能影响这种新兴变体的传播、细胞病变效应和免疫逃逸。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/5e49e525c226/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/63698a65e652/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/c53849acde41/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/ba1ffc70385c/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/99ca1050b974/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/cafea289a985/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/6b90cbfad8ea/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/5e49e525c226/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/63698a65e652/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/c53849acde41/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/ba1ffc70385c/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/99ca1050b974/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/cafea289a985/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/6b90cbfad8ea/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/5e49e525c226/gr6_lrg.jpg

相似文献

1
Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529.新兴 SARS-CoV-2 变体 B.1.1.529 的刺突糖蛋白的功能特性。
Cell Rep. 2022 Jun 14;39(11):110924. doi: 10.1016/j.celrep.2022.110924. Epub 2022 May 20.
2
Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.刺突蛋白结构特征、决定病毒进入宿主细胞的物种特异性血管紧张素转换酶 2 残基,以及奥密克戎 BA.1、BA.1.1、BA.2 和 BA.3 变异株的抗体中和逃逸。
J Virol. 2022 Sep 14;96(17):e0114022. doi: 10.1128/jvi.01140-22. Epub 2022 Aug 24.
3
Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission.温度依赖性的奥密克戎亚变种的 Spike-ACE2 相互作用与病毒传播有关。
mBio. 2024 Aug 14;15(8):e0090724. doi: 10.1128/mbio.00907-24. Epub 2024 Jul 2.
4
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.SARS-CoV-2 变体 B.1.617.1 (Kappa)、B.1.617.2 (Delta) 和 B.1.618 的细胞进入和免疫逃逸特性。
mBio. 2022 Apr 26;13(2):e0009922. doi: 10.1128/mbio.00099-22. Epub 2022 Mar 10.
5
Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant.SARS-CoV-2 B.1.1.529(奥密克戎)变体的免疫逃逸和宿主范围扩展的进化。
mBio. 2023 Apr 25;14(2):e0041623. doi: 10.1128/mbio.00416-23. Epub 2023 Apr 3.
6
Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.弗林蛋白酶裂解位点的获得和进一步的 SARS-CoV-2 进化改变了病毒进入、感染传播和细胞信号转导的机制。
J Virol. 2022 Aug 10;96(15):e0075322. doi: 10.1128/jvi.00753-22. Epub 2022 Jul 25.
7
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.SARS-CoV-2 刺突 RBD 中的 V367F 突变增强了与人类 ACE2 受体的结合亲和力,从而提高了病毒的感染性。
J Virol. 2021 Jul 26;95(16):e0061721. doi: 10.1128/JVI.00617-21.
8
Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2.SARS-CoV-2 奥密克戎变异株 BA.1 和 BA.2 中刺突感染力、加工和中和的决定因素。
Cell Host Microbe. 2022 Sep 14;30(9):1255-1268.e5. doi: 10.1016/j.chom.2022.07.006. Epub 2022 Jul 18.
9
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.SARS-CoV-2 刺突蛋白 D614G 突变增加了病毒粒子刺突密度和感染力。
Nat Commun. 2020 Nov 26;11(1):6013. doi: 10.1038/s41467-020-19808-4.
10
Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation.运用计算模型研究了 5 种突变对 ACE2 受体结构的影响,及其与 SARS-CoV-2 一些新兴变异株感染性和毒力的相关性,结果提示了结合亲和力失调的机制。
Chem Biol Interact. 2022 Dec 1;368:110244. doi: 10.1016/j.cbi.2022.110244. Epub 2022 Nov 3.

引用本文的文献

1
Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon.喀麦隆个体感染新型冠状病毒后针对刺突蛋白的纵向体液免疫
Virology. 2025 Apr;605:110467. doi: 10.1016/j.virol.2025.110467. Epub 2025 Feb 25.
2
SARS-CoV-2 Omicron variations reveal mechanisms controlling cell entry dynamics and antibody neutralization.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变体揭示了控制细胞进入动态和抗体中和的机制。
PLoS Pathog. 2024 Dec 2;20(12):e1012757. doi: 10.1371/journal.ppat.1012757. eCollection 2024 Dec.
3
The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids.

本文引用的文献

1
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.南非出现奥密克戎后,SARS-CoV-2 再感染的风险增加。
Science. 2022 May 6;376(6593):eabn4947. doi: 10.1126/science.abn4947.
2
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.Covid-19 疫苗对奥密克戎(B.1.1.529)变异株的有效性。
N Engl J Med. 2022 Apr 21;386(16):1532-1546. doi: 10.1056/NEJMoa2119451. Epub 2022 Mar 2.
3
The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0-3.3 Days Can Be Explained by Immune Evasion.
TMPRSS2和组织蛋白酶在人呼吸道类器官中对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的各自作用。
J Virol. 2025 Jan 31;99(1):e0185324. doi: 10.1128/jvi.01853-24. Epub 2024 Nov 27.
4
Strengths and limitations of SARS-CoV-2 virus-like particle systems.严重急性呼吸综合征冠状病毒2型病毒样颗粒系统的优势与局限性
Virology. 2025 Jan;601:110285. doi: 10.1016/j.virol.2024.110285. Epub 2024 Nov 5.
5
Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain.针对 Spike N 端结构域 N1/N2 环的奥密克戎特异性超强 SARS-CoV-2 中和抗体。
Emerg Microbes Infect. 2024 Dec;13(1):2412990. doi: 10.1080/22221751.2024.2412990. Epub 2024 Oct 28.
6
Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission.温度依赖性的奥密克戎亚变种的 Spike-ACE2 相互作用与病毒传播有关。
mBio. 2024 Aug 14;15(8):e0090724. doi: 10.1128/mbio.00907-24. Epub 2024 Jul 2.
7
Molecular characterization of SARS-CoV-2 Omicron clade and clinical presentation in children.奥密克戎变异株的分子特征及儿童临床表现。
Sci Rep. 2024 Mar 4;14(1):5325. doi: 10.1038/s41598-024-55599-0.
8
Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity.SARS-CoV-2 奥密克戎刺突蛋白 S2 亚基的突变强烈影响其构象、融合性和中和敏感性。
J Virol. 2023 Nov 30;97(11):e0092223. doi: 10.1128/jvi.00922-23. Epub 2023 Oct 20.
9
Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking.靶向 SARS-CoV-2 刺突糖蛋白四元结构域的抗体通过构象锁定防止病毒受体结合。
Immunity. 2023 Oct 10;56(10):2442-2455.e8. doi: 10.1016/j.immuni.2023.09.003. Epub 2023 Sep 29.
10
Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages.SARS-CoV-2 刺突蛋白的适应性变异:对不同病毒-细胞进入阶段的影响。
mBio. 2023 Aug 31;14(4):e0017123. doi: 10.1128/mbio.00171-23. Epub 2023 Jun 29.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株奥密克戎以2.0至3.3天的倍增时间传播可由免疫逃逸来解释。
Viruses. 2022 Jan 30;14(2):294. doi: 10.3390/v14020294.
4
Cryo-EM structure of the SARS-CoV-2 Omicron spike.SARS-CoV-2 奥密克戎刺突蛋白的冷冻电镜结构。
Cell Rep. 2022 Mar 1;38(9):110428. doi: 10.1016/j.celrep.2022.110428. Epub 2022 Feb 7.
5
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.新冠病毒奥密克戎改变 TMPRSS2 的使用方式影响其感染性和融合性。
Nature. 2022 Mar;603(7902):706-714. doi: 10.1038/s41586-022-04474-x. Epub 2022 Feb 1.
6
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.mRNA-1273加强疫苗接种后对SARS-CoV-2奥密克戎变体的中和作用。
N Engl J Med. 2022 Mar 17;386(11):1088-1091. doi: 10.1056/NEJMc2119912. Epub 2022 Jan 26.
7
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.尽管接种了mRNA疫苗加强针,但仍出现了新冠病毒奥密克戎变异株突破性感染。
Lancet. 2022 Feb 12;399(10325):625-626. doi: 10.1016/S0140-6736(22)00090-3. Epub 2022 Jan 18.
8
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant.mRNA 加强免疫可引发针对 SARS-CoV-2 奥密克戎变异株的强效中和血清活性。
Nat Med. 2022 Mar;28(3):477-480. doi: 10.1038/s41591-021-01676-0. Epub 2022 Jan 19.
9
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.奥密克戎变异株对抗体介导的中和作用具有高度抗性:对控制 COVID-19 大流行的影响。
Cell. 2022 Feb 3;185(3):447-456.e11. doi: 10.1016/j.cell.2021.12.032. Epub 2021 Dec 24.
10
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.奥密克戎对抗体中和作用的逃逸显著。
Nature. 2022 Feb;602(7898):671-675. doi: 10.1038/s41586-021-04389-z. Epub 2021 Dec 23.